From 2013 to 2023, the import of pharmaceutical products to the Netherlands experienced significant fluctuations, peaking at various intervals. In 2013, the value stood at $16.797 billion, reaching a low in 2015 at $12.808 billion, and rebounding to $14.717 billion by 2023. The most notable year-on-year change occurred in 2015 with a dramatic decrease of 23.02%, followed by a more stable trend with minor fluctuations. Recent years (2022-2023) show a slight increase of 1.2% after a previous drop of 7.96%. The Compound Annual Growth Rate (CAGR) over the last 5 years is around 1.4%.
Future trends indicate a moderate growth trajectory, with forecasted values reaching $15.612 billion by 2028. The forecasted 5-year CAGR is expected to be 0.8%, with a 5-year overall growth rate of 4.08%. This suggests a stable yet slow-paced increase in pharmaceutical imports.
Future trends to watch:
- The global economic climate's impact on pharmaceutical imports.
- Regulatory changes within the EU and their effect on trade.
- Advancements in healthcare technology influencing import demands.
- Potential disruptions from international supply chain issues.
